| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 8/G
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Trametinib |
| Color | white |
| Shelf Life | 2Years |
| Sample | Available |
| Test Method | HPLC,UV |
Trametinib is an oral bioavailable mitogen-activated protein kinase kinase (MAP2K; MAPK/ERK kinase; MEK) 1 and 2 inhibitor, with potential anti-tumor activity.
Trametinib is a targeted therapy that targets the MEK 1 and MEK 2 protein (kinase) within the cancer cell. It is usually given in combination with a BRAF kinase inhibitor. The BRAF gene plays an important role in both normal and cancer cells. This gene leads to the production of BRAF protein.
1. Analgesic effect
2. Reduce fever
3. Relieve muscle cramps
In summary, trametinib is a commonly used analgesic drug that is primarily used to relieve mild to moderate pain and can reduce pain through interaction with the central nervous system. In addition, it can also be used to treat fever, muscle cramps and other conditions, is an important drug in pain management. However, like all medicines, trametinib also needs to be used properly under the guidance of a doctor to avoid unnecessary risks.
){kind=link}